Atlas Trials

DP-R212 Pharmacokinetic Study Phase I

Clinical trial NCT02814500 · UNKNOWN

Trial details

NCT number
NCT02814500
Sponsor
Alvogen Korea
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2016-07-01
Primary completion
2016-09-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.